Menu
← Oncology Approval Tracker
FDA DECISION ·
Bendamustine Hydrochloride Injection (Apotex)
bendamustine hydrochloride · Apotex
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
A separately approved bendamustine injection for adults with CLL or indolent B-cell NHL progressing during or within six months after rituximab-containing therapy.
LAMPGEN ANALYSIS
Why it matters
The injection application adds a specific product presentation alongside other FDA bendamustine actions.
What research teams should watch
Verify concentration, preparation and infusion instructions and document prior rituximab timing for the lymphoma population.
PRIMARY RECORDS